Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Christopher Cates Manor View
Practice, Bushey Health Centre, Bushey, Hertfordshire WD2 2NN
chriscates{at}email.msn.com
Two recent reviews questioned the routine use of
antibiotics in the initial management of acute otitis
media.
1 2
My practice partners and I responded to the
reviews by changing our policy, with the aim of reducing such
prescribing in children. We measured the change one year after adopting
the new policy.
From July 1997 my practice partners and I changed our
policy on routine prescription of antibiotics in the initial management of acute otitis media in children. In children who were not
particularly ill we gave the parents a handout that summarised the
limited benefit of antibiotics on the basis of the data presented in
the Cochrane review.1 We advised parents to give regular
paracetamol suspension; we also offered an antibiotic prescription but
asked the parents to keep it for a day or two. They could redeem it at
a pharmacy if the child did not got better over this period.
A local practice acted as a concurrent control. Both practices use
amoxicillin suspension as the antibiotic of choice in children with
acute otitis media, and, although the doctors in the control practice
were aware of the new evidence, they did not use the handout or use
deferred prescriptions. Monthly prescribing rates of all amoxicillin
suspensions were obtained for each practice from the district health
authority. The 12 months before July 1997 were used for baseline
comparison, and the following 12 months were used to assess the impact
of our change in policy. Both practices had closely similar list sizes
(about 11 000 patients) throughout the study. As there was seasonal
and annual variation in prescribing levels, monthly odds of
prescriptions issued in relation to the national total were calculated
for each practice; these were weighted and pooled by using the
Mantel-Haenszel method.3
Prescriptions for other antibiotic suspensions were also checked in our
practice by comparing figures from the reports on level 3 prescribing
analysis and cost data (PACT) with national figures, to check that
other antibiotics were not being substituted for amoxicillin.
The table shows the monthly prescriptions for amoxycillin suspension
for each practice, along with national totals. The median number of
prescriptions per month in our practice fell from 75 to 47 after the
change (median difference
In the six months after the change in policy the number of antibiotic
suspensions prescribed in our practice was 19% lower (16% to 21%)
than in the same six months of the previous year. Over this period
national prescribing of all antibiotic suspensions fell by
3%.4
Before my partners and I changed our policy, acute otitis
media accounted for over half of all antibiotics prescribed for children in our practice. After our change in policy the proportion fell to a third, and as a consequence total antibiotic use for all
infections in childhood fell by one fifth. As the evidence is not yet
available to identify which children with acute otitis media benefit
most from antibiotics we deferred prescriptions in those who were not
systemically unwell (as suggested in the editorial comment accompanying
one of the reviews in the BMJ 5).
We found that most parents welcomed the written handout. The deferred
prescription also acted as a safety net while they waited to see if the
ear infection would resolve by itself and was often not redeemed. We
are continuing with this policy, and in the current battle against
antimicrobial resistance we would commend this approach to initial
management of acute otitis media as a way of reducing the antibiotic
load on children in the community.
A copy of the leaflet given to patients can be supplied by the author. I thank my partners (Drs T Boyd, B Bintcliffe, J Glover, M
Buist, and P Davis) for taking part in the study and the control practice for allowing me the use of their prescribing data; Mrs Frances
Wilson (West Hertfordshire Health Authority) for providing prescribing
data for both practices; Dr John Ferguson (medical director of the
Prescription Pricing Authority, Newcastle upon Tyne) and Mr A M Savva
(Statistics Division 1E of the Department of Health) for providing the
national figures; Iain Chalmers and Professor C Del Mar for helpful
comments; and Dr M Cucherat for use of the software package to perform
the Mantel-Haenszel analysis.
Contributors: CC had the original idea for the study, collected
and analysed the data, and drafted and revised the paper. His partners
helped him to construct the handout. CC is the guarantor for the paper.
Funding: NHS Executive (North Thames) provided funding for
protected time for CC.
Competing interests: None declared.
(Accepted 10 December 1998)
![]()
Methods and results
Top
Methods and results
Comment
References
30.5 (95% confidence interval
14 to
31, 2P=0.0065, Mann-Whitney U test). Compared with the national
levels, the fall in prescribing amoxicillin suspension in our practice
was
32% (
25% to
39%) and in the control practice was
12% (
4% to
20%).
![]()
Comment
Top
Methods and results
Comment
References
![]()
Acknowledgments
![]()
References
Top
Methods and results
Comment
References
© BMJ 1999
Read all Rapid Responses
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.